Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you. Thanks!

MEDVi vs Ro: Which GLP-1 Weight Loss Program Is Better in 2026?

By WPG Research TeamPublished: Last updated:

Disclosure: Some links on this site are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you. Thank you for supporting our site.·For informational purposes only—not medical advice.

Bottom Line (March 2026)

Paying cash (no insurance)? MEDVi is usually the better value — one flat monthly price covers medication, provider, and shipping.

Have insurance that covers GLP-1s? Ro is usually the better fit — their insurance concierge can get your plan to cover brand-name Wegovy or Zepbound.

Biggest tradeoff: MEDVi uses compounded medication (not FDA-approved as a finished product). Ro's primary path is FDA-approved brand-name medication.

MEDVi vs Ro comparison showing side-by-side analysis of GLP-1 weight loss programs

One program starts at $179 for month one, then $299/month with medication included. The other starts at $39, then $149/month — before you pay for the medication itself. That pricing difference is one of the most common questions in this space — and likely why you're comparing these two right now.

Here's the straight answer on MEDVi vs Ro: for most people paying cash (no insurance coverage for weight loss drugs), MEDVi is typically the better value — a single flat price covers your doctor's evaluation, the medication, supplies, and shipping. There's no membership fee. If you have strong commercial insurance that covers brand-name drugs like Wegovy or Zepbound, Ro's insurance concierge service can make it cheaper by getting your plan to foot the medication bill.

But price is only one piece. The medications are different. The safety considerations carry different tradeoffs. And your insurance situation changes the math entirely.

Below is a full breakdown using verified pricing from both providers' official pages, FDA prescribing labels, and thousands of public patient reviews on Trustpilot and ConsumerAffairs.

MEDVi vs Ro — Side-by-Side Comparison (March 30, 2026)

Prices last verified: March 30, 2026

Here's the full picture before we go deep on anything. Bookmark this — you'll probably come back to it.

FeatureMEDViRo (Body Program)What This Means for You
Monthly Membership Fee$0 — no membership$149/mo ($39 first month)MEDVi has no platform fee; Ro's membership is charged even without meds
Medication Included in Price? Yes No — billed separatelyMEDVi's price is your total; Ro's price is before adding medication
First Month Total (Semaglutide)$179$194-$244 ($39 + $149-$199 meds)Near-equal at month 1; the gap shifts depending on dose
Ongoing Monthly Total (Semaglutide)$299 (locked at all dose levels)$294-$494 ($149 + $149-$349 meds, varies by dose)MEDVi's price stays flat; Ro's increases as dose goes up
Year 1 Estimate (Cash Pay, Semaglutide)~$3,468~$3,428-$5,828 (depends on medication form + dose)At the lowest starting dose, costs are similar; at higher doses, MEDVi's locked pricing pulls ahead
Medication TypeCompounded GLP-1sFDA-approved brand-name (Wegovy, Foundayo, Zepbound KwikPen/vials, Ozempic) + compounded optionsKey tradeoff: cost savings vs. FDA-approved label
Oral / Needle-Free Option Sublingual tablets Wegovy pill (daily tablet)Both have needle-free paths; different products
Insurance Accepted Cash-pay only (HSA/FSA accepted) Insurance concierge for medicationIf your plan covers GLP-1s, Ro helps file the paperwork
ContractsNone — month to monthNone — cancel anytimeNeither locks you in
Money-Back Guarantee Medical disqualification only No guaranteeMEDVi refunds only if you are medically disqualified after paying — not for ordinary cancellation or dissatisfaction
Approval Speed24-48 hours typicalCash pay: ~1 week. Insurance: 1-3+ weeksMEDVi gets you started fastest
24/7 Support Unlimited messaging Messaging + health coachingBoth offer round-the-clock access; Ro adds structured coaching
Available States49 states (all except North Dakota)All 50 + DCMEDVi excludes North Dakota; Ro is fully nationwide
Trustpilot Rating 4.4 / 5 (11,498 reviews) 3.8 / 5 (3,153 reviews)MEDVi has more reviews and a higher average score
Lab WorkIncluded if clinically needed (Quest)May be required — costs and logistics vary; confirm during enrollmentMEDVi covers labs when needed; confirm Ro's lab policy at signup
CoachingProvider guidance + unlimited messaging Structured coaching curriculumRo's coaching is more formalized
Pharmacy PartnerBelmar Pharma Solutions (est. 1985, FDA-registered facilities)In-house + integrates with LillyDirect / NovoCare programsMEDVi uses established compounding pharmacy; Ro integrates with manufacturer programs

Three factors drive most decisions here: pricing structure (all-inclusive vs. membership + separate meds), medication type (compounded vs. FDA-approved brand-name), and whether your insurance changes the math. Other factors — coaching depth, app experience, speed of approval — matter too, depending on your priorities. We'll cover all of them.

MEDVi vs Ro at a glance comparison infographic showing key differences between both GLP-1 programs

The core tradeoff, stated plainly:

MEDVi is cheaper because it uses compounded medications — not FDA-approved finished products. If having the FDA-approved label matters to you, MEDVi cannot provide that. Ro can. Conversely, Ro's total cost for cash-pay patients is significantly higher — and that gap grows as your dose increases. Neither tradeoff is trivial. The rest of this article helps you decide which one matters more for your specific situation.

How Much Does MEDVi vs Ro Actually Cost? The Real Math Nobody Shows You

This is where most comparisons fall apart. They flash an intro price and move on. We're going to show you month 1, month 2, and the full first year — because that's what actually matters when you're budgeting for a treatment you might be on for a while.

Understanding the Two Pricing Models

Ro and MEDVi use fundamentally different pricing structures, and understanding the difference is essential for comparing costs accurately.

Ro charges a monthly membership fee ($149/month) that covers provider access, coaching, and the platform — your GLP-1 medication is billed separately on top of that. This structure makes sense for Ro's model because insurance may cover part or all of the medication cost, making the total potentially much lower than it appears.

MEDVi bundles everything into one monthly price ($299/month for compounded semaglutide) — medication, provider, supplies, and shipping. No separate line items. This model is simpler to budget for but doesn't offer an insurance pathway to reduce costs.

MEDVi Pricing — What You'll Actually Pay

Prices last verified: March 30, 2026

ProgramFirst MonthOngoing MonthsWhat's Included
Semaglutide injection$179$299/mo (locked at all dose levels)Everything: provider review, medication, supplies, shipping, 24/7 messaging
Tirzepatide injectionStarting at $349Pricing increases with dose — confirm refill rate in checkoutSame as above
Semaglutide sublingual tablets (oral)Starting at $249Pricing varies by dose — confirm refill rate in checkoutSame as above — no needles
Tirzepatide sublingual tablets (oral)Starting at $279Pricing varies by dose — confirm refill rate in checkoutSame as above — no needles

No membership fee. No consultation fee. No platform fee. No separate pharmacy charge.

The only verified "locked" refill price we can confirm from MEDVi's published materials is $299/month for compounded semaglutide injections. For other medication options, introductory pricing is published but refill rates may vary — confirm during checkout before enrolling.

Month-to-month. No long-term contracts. To avoid being charged for the next billing cycle, cancel at least 72 hours before your next billing date via the patient portal chat or [email protected]. Ordinary cancellation does not trigger a refund — see the refund section below for details.

Source: MEDVi.org official pricing page, verified March 30, 2026

Ro Pricing — What You'll Actually Pay

Prices last verified: March 30, 2026

Line ItemFirst MonthOngoing Months
Membership fee (required)$39$149/mo
Wegovy pill (oral semaglutide)+$149/mo (starting dose)+$199-$299/mo (higher doses)
Wegovy pen (semaglutide injection)+$199/mo (promo, first 2 months through March 2026)+$349/mo (higher doses)
Zepbound vials (tirzepatide injection)+$299/mo (2.5mg starting dose)+$399-$449/mo (higher doses)

Your real monthly total with Ro: $294 to $594+ depending on medication type and dose. Ro states their cash-pay medication pricing matches LillyDirect, NovoCare, and TrumpRx rates.

Note: Ro's medication prices are "starting at" figures and increase at higher doses. Most patients require dose increases over time for full therapeutic effect.

The insurance exception: If your insurance covers the medication, your cost drops to the $149 membership plus your copay — potentially $170-$195/month total. That's genuinely cheaper than MEDVi. This is Ro's strongest selling point.

Source: Ro.co/weight-loss/pricing, verified March 30, 2026

Note: Ro's website lists a $99 "GLP-1 Screening" option that lets you complete their medical evaluation before committing to the $149/month membership. This can be useful for confirming eligibility first — but it is not part of their ongoing pricing structure. Think of it as a one-time intake fee if you want to test the waters before subscribing.

Year 1 Cost — Realistic Scenarios

We built this using only verified, published pricing from each provider's official pages. Ro's medication prices are "starting at" figures — they increase at higher doses.

Ro membership cost (Year 1): $39 first month + ($149 x 11 months) = $1,678 in membership alone before any medication.

ScenarioMEDVi (Year 1)Ro (Year 1)What This Tells You
MEDVi semaglutide injections vs Ro Wegovy pill (starting dose)$3,468 ($179 + $299 x 11)~$3,428 ($1,640 membership + $149 x 12 med)Nearly identical at the starting dose — but Wegovy pill increases to $199-$299/mo at higher doses
MEDVi semaglutide injections vs Ro Wegovy pen$3,468~$5,030-$5,828 ($1,640 + pen pricing at maintenance doses)MEDVi saves ~$1,500-$2,300 vs Ro's injection path
MEDVi semaglutide injections vs Ro Zepbound vial$3,468 (comparing semaglutide to tirzepatide)~$5,228-$7,028 ($1,640 + $299-$449 x 12)Different drugs, but shows cost range
Ro with good insurance ($50/mo copay)$3,468 (no insurance option)~$2,240 ($1,640 + $50 x 12)Ro wins clearly when insurance covers the medication

Sources: MEDVi.org pricing page; Ro.co/weight-loss/pricing; verified March 30, 2026. Ro medication prices shown are published "starting at" amounts and increase at higher doses — confirm current pricing during checkout.

The critical insight most comparison sites miss: MEDVi's $299/month is locked regardless of what dose you're on. Ro's medication cost increases as your provider titrates you to higher doses — and most patients need higher doses for full therapeutic effect. At the lowest starting dose, Ro's Wegovy pill is price-competitive with MEDVi. But as treatment progresses and doses increase, the gap widens in MEDVi's favor.

The insurance reality: Coverage for GLP-1 weight loss medications varies widely by plan. Many commercial plans still exclude them. Medicare Part D historically excluded weight-loss drugs, but the Medicare GLP-1 Bridge (launched July 1, 2026) now covers Wegovy and Zepbound for eligible beneficiaries at $50/month through December 31, 2027. Even with covered plans, prior authorization can take weeks with no guarantee of approval. If your plan does cover GLP-1s, Ro's insurance concierge is a genuine advantage worth pursuing. If it doesn't — or if you don't want to wait — MEDVi's predictable all-inclusive pricing eliminates that uncertainty.

What About Hidden Fees?

We looked. Here's what to know:

MEDVi: The first-month price ($179 for semaglutide) jumps to $299 for month 2 and beyond. This is clearly stated on their site, but some reviewers express surprise when the second charge hits. It's not hidden — it's an introductory rate. Just know it going in and budget for the ongoing price.

Ro: The $149 membership fee continues billing monthly whether or not you receive medication that month. If you're waiting on insurance approval or between prescriptions, you're still paying. Multiple reviewers flag this as a frustration point.

Neither of these is a "scam." Both are standard business practices. But you should understand them before you enter your credit card.

MEDVi vs Ro Medications: Compounded vs FDA-Approved (The Honest Explanation)

This is the most important section of this entire article. The medication question is bigger than the price question — because what you're putting in your body should matter more than what you're pulling from your wallet.

What MEDVi Prescribes

MEDVi operates as a hybrid platform — they offer both compounded GLP-1 medications through their core all-inclusive plans and access to FDA-approved brand-name medications through a separate membership route.

Core compounded plans (all-inclusive pricing): MEDVi prescribes compounded versions of semaglutide and tirzepatide prepared by Belmar Pharma Solutions, a compounding pharmacy that has operated since 1985.

  • Compounded semaglutide injection — $179 first month, $299/mo ongoing
  • Compounded tirzepatide injection — starting at $349
  • Sublingual semaglutide tablets (daily, no needles) — starting at $249
  • Sublingual tirzepatide tablets (daily, no needles) — starting at $279

Brand-name membership route ($99/month membership + medication cost): MEDVi also offers a separate $99/month membership that provides access to FDA-approved brand-name medications — including Wegovy injection, Wegovy pill (oral semaglutide), and Zepbound injection. Under this route, the medication cost is billed separately, similar to Ro's model. This option is best suited to patients who specifically want brand-name medications but prefer MEDVi's platform.

What Ro Prescribes

Ro primarily prescribes FDA-approved, brand-name GLP-1 medications:

  • Wegovy (semaglutide injection) — FDA-approved for chronic weight management
  • Wegovy pill (oral semaglutide tablet) — the newest option, daily pill
  • Zepbound (tirzepatide injection) — FDA-approved for chronic weight management
  • Ozempic (semaglutide injection) — FDA-approved for type 2 diabetes, sometimes prescribed off-label for weight loss

Ro integrates directly with Eli Lilly's LillyDirect program and Novo Nordisk's NovoCare — these are manufacturer-backed access programs that can provide brand-name medication at reduced cash-pay prices or through insurance. This direct manufacturer relationship means Ro patients can access the exact same FDA-approved medications (same manufacturer, same formulation, same quality controls) that would be dispensed at a retail pharmacy.

For patients who prioritize the FDA-approved label and the clinical trial evidence behind it, this is Ro's strongest differentiator. You're getting the exact product that went through rigorous FDA review — not a compounded version, not a generic equivalent, the actual branded medication from the actual manufacturer.

MEDVi vs Ro GLP-1 medication map showing compounded and FDA-approved options available through each provider

Compounded vs. FDA-Approved — What You Need to Know (The Full Truth)

We're going to be completely transparent here because you deserve it.

Compounded GLP-1 medications are not FDA-approved as finished products. The FDA does not review compounded drugs for safety, effectiveness, or quality before they reach patients. This is true across the entire compounding industry — not unique to MEDVi.

The FDA has raised specific, legitimate concerns about some compounded GLP-1 products in the marketplace:

  • Some products arrived warm or without adequate cold-chain shipping
  • Dosing errors from inconsistent labeling (some labels used "units" instead of milligrams, causing patients to take 5-20x their intended dose)
  • Fraudulent labels listing pharmacies that didn't actually make the product
  • Some compounders using untested salt forms of semaglutide (like semaglutide sodium) with unknown safety profiles
  • In February 2026, the FDA announced plans to restrict GLP-1 ingredients used in unapproved compounded products and crack down on misleading marketing

Source: FDA — "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss," updated February 4, 2026; FDA press announcement, February 6, 2026

These are real concerns. And they matter.

The FDA's enforcement actions are primarily aimed at the worst actors — the fly-by-night operations, the companies selling products labeled "for research use only," the outfits using foreign-sourced ingredients with no quality testing, the firms making marketing claims that their compounded products are "the same as" or "generic versions of" FDA-approved drugs. The FDA sent over 50 warning letters to such companies in September 2025.

Not every compounding operation is equal. And that's where MEDVi's specific setup matters:

MEDVi's pharmacy partner — Belmar Pharma Solutions — is not a startup. They've been compounding medications since 1985. They operate six facilities across the country, including both 503A state-licensed pharmacies and FDA-registered 503B outsourcing facilities. They source ingredients exclusively from FDA-registered suppliers. Every batch undergoes independent lab testing. They follow cGMP (current Good Manufacturing Practice) protocols — the same federal manufacturing standards that major pharmaceutical companies must meet. They ship to 49 states (all except North Dakota) and are licensed accordingly.

MEDVi itself is LegitScript certified — meaning it undergoes ongoing, independent monitoring for compliance with pharmacy laws, healthcare regulations, and advertising standards. LegitScript certification is the same standard required by Google for healthcare advertising and by many payment processors for pharmacy transactions.

Does this make compounded medications identical to FDA-approved drugs? No. The FDA is explicit: companies cannot claim equivalence. We won't either.

Does it make MEDVi one of the more credible providers in this space? Based on the data — 500,000+ patients treated (per MEDVi), 4.4 stars from 11,498 Trustpilot reviews, a 39-year-old pharmacy partner with FDA-registered facilities, and LegitScript certification — the evidence says yes.

The practical way to think about it: Brand-name Wegovy and Zepbound went through rigorous FDA trials and carry the FDA-approved label. That's valuable. But those drugs cost $1,000-$1,500 per month without insurance — a price most Americans simply can't afford. Compounded medications from established, regulated pharmacies exist because that price gap is unsustainable, and millions of people need access to these treatments.

If having the FDA-approved stamp is non-negotiable for you: choose Ro. If you're comfortable with a compounded medication from a pharmacy that's been operating for nearly four decades under state and federal oversight, and you want to save $1,800-$2,300+ per year: MEDVi is worth serious consideration.

Clinical Trial Results — What "Good" Weight Loss Looks Like

These numbers come from the trials that led to FDA approval. They represent the best available evidence for what semaglutide and tirzepatide can do:

Semaglutide 2.4mg (the dose used for weight loss):

  • 14.9% average body weight loss over 68 weeks (vs. 2.4% with placebo)
  • 86% of participants lost at least 5% of their body weight
  • 69% lost at least 10%
  • 50% lost at least 15%

For a 220-pound person, that's roughly 33 pounds on average.

Source: Wilding et al., STEP 1 trial, NEJM 2021

Tirzepatide (highest dose):

  • 20.9% average body weight loss over 72 weeks (vs. 3.1% with placebo)
  • Intermediate doses showed 15.0% and 19.5% weight loss

For a 220-pound person, that's roughly 46 pounds on average at the highest dose.

Source: Jastreboff et al., SURMOUNT-1 trial, NEJM 2022

MEDVi vs Ro clinical trial results showing semaglutide and tirzepatide weight loss data

Important framing: These results came from clinical trials using FDA-approved branded medications with structured lifestyle interventions. They represent what's possible with these drug molecules under controlled conditions — not a guarantee from any particular telehealth program or any compounded formulation. Individual results vary, and compounded medications have not been independently tested in comparable clinical trials. That said, many MEDVi patients report meaningful weight loss — the reviews below describe losses of 13, 22, 29, and 31+ pounds over several months.

Side Effects & Safety: Does It Matter Which Provider You Choose?

The side effects come from the medication itself — not from the company that ships it to you. Whether you get semaglutide from MEDVi, Ro, your local doctor, or a retail pharmacy, the side effect profile is the same.

Common Side Effects (What Most People Experience)

These are reported most frequently in clinical trials and typically hit hardest during the first 2-4 weeks while your body adjusts. They usually improve significantly with time and proper dose titration:

  • Nausea — the single most common complaint. It fades for most people within weeks.
  • Constipation or diarrhea — varies by person; staying hydrated helps
  • Reduced appetite — this is actually the medication working as intended
  • Headache or fatigue — usually temporary during the first few weeks
  • Mild injection site reactions — for injectable versions; generally minor

The standard approach is to start at the lowest dose and increase gradually. This minimizes side effects dramatically. Both MEDVi and Ro follow this titration protocol.

Serious Warnings (Read Before You Start Either Program)

GLP-1 medications carry an FDA boxed warning about thyroid C-cell tumors. In animal studies, both semaglutide and tirzepatide caused thyroid tumors. Whether this happens in humans is not yet known.

Do NOT use GLP-1 medications if you have:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Other serious but less common risks: pancreatitis, gallbladder problems, kidney injury, hypoglycemia (especially with diabetes medications), and severe allergic reactions.

Source: FDA Prescribing Information — Wegovy (semaglutide); Zepbound (tirzepatide)

MEDVi vs Ro safety checklist showing GLP-1 medication side effects and safety considerations

Where the Provider Choice Actually Affects Safety

The medication side effects are identical regardless of provider. Where the providers differ:

Support when side effects hit: MEDVi offers unlimited 24/7 messaging with your care team. If nausea hits at 10 PM on a Saturday, you can message and get guidance on managing symptoms or adjusting your dose. You're not waiting until Monday for a callback. Ro also provides unlimited messaging plus scheduled monthly provider check-ins and a structured health coaching curriculum.

The coaching difference is worth understanding. Ro's Body program includes educational modules on nutrition, movement, sleep, and stress management — a guided curriculum that runs alongside the medication. MEDVi's approach is more provider-direct: unlimited access to your care team for medical questions, dosing support, and treatment adjustments, but without a formalized coaching track.

Which is better? Depends on you. If you thrive with structured programs and accountability modules, Ro's coaching adds genuine value. If you prefer fast, direct access to a medical provider without the extra curriculum, MEDVi's model is cleaner and more focused.

Medication handling and shipping: For injectable GLP-1s, cold-chain shipping is non-negotiable. The FDA has specifically flagged cases where compounded injectables arrived warm or without adequate ice packs — and using improperly stored medication can affect its quality and safety. MEDVi ships via FedEx with temperature-controlled packaging. Multiple reviewers confirm receiving medication cold and properly packed. Ro ships through their pharmacy network with similar cold-chain protocols.

If your medication ever arrives warm — from any provider:

Don't assume it's safe to use. Follow the storage instructions included with your medication. Contact your provider or pharmacy immediately, take photos of the packaging and ice pack condition, note the date and time of delivery, and ask whether a replacement shipment is needed. Reputable providers will replace compromised shipments at no additional charge.

How Each Program Actually Works (Step by Step)

Getting Started With MEDVi

  1. Complete a free online health assessment — takes about 5 minutes. Medical history, current medications, weight loss goals.
  2. A licensed provider reviews your case — typically within 24-48 hours. If your health history warrants it (thyroid issues, diabetes, liver/kidney conditions), they'll order labs at no extra cost through Quest Diagnostics. If you have recent lab results, you can upload those instead.
  3. If approved, your prescription goes to the pharmacy — medication ships directly to your door in temperature-controlled packaging.
  4. Ongoing care — unlimited messaging with your care team anytime, video appointments available, dose adjustments as needed based on your progress and tolerance.
  5. Billing — month-to-month, cancel with 72 hours notice.

Most MEDVi patients go from sign-up to medication-in-hand within a week. Some in as few as 3-4 days.

Getting Started With Ro

  1. Complete an online health intake — $39 first-month membership charged at sign-up.
  2. A Ro-affiliated provider reviews your information — may order lab work (Quest locations included with membership, or $75 at-home kit).
  3. Choose your path:
    • Insurance route: Ro's concierge team works with your insurance on prior authorization for brand-name medication. This process can take 2-3 weeks or longer depending on your plan.
    • Cash-pay route: Medication can ship within about a week. No insurance delays.
  4. Ongoing care — monthly provider check-ins, unlimited messaging, health coaching curriculum, and an app-based experience for tracking progress.
  5. Billing — $149/month membership ongoing (medication separate). Cancel anytime.

Speed Comparison — Who Gets You Started Faster?

ScenarioMEDViRo
Fastest possible start~3-4 days (approval + shipping)~5-7 days (cash-pay path)
Most common timeline~5-7 days~7-14 days (depends on path)
Insurance authorization routeN/A (cash-pay only)2-6+ weeks (varies by insurer)

If speed is a priority for you, MEDVi has a clear edge — most patients have medication in hand within days vs. a week or more with Ro's cash-pay path (and potentially weeks with the insurance route).

What to Expect in Your First Month (Either Program)

Regardless of which provider you choose, here's what the first 30 days typically look like. Setting realistic expectations now prevents frustration later:

Week 1-2: You'll start at the lowest medication dose. This is intentional and important — starting low minimizes side effects and lets your body adjust gradually. You may notice mild nausea, reduced appetite, or slight fatigue. Some people feel the appetite suppression immediately; others take a couple of weeks. Don't expect dramatic weight loss yet. Your body is calibrating.

Week 2-3: Side effects typically peak here and then start improving. Most patients report that nausea (if present) becomes noticeably more manageable. Your appetite will likely be significantly reduced — meals you used to finish easily now leave you satisfied halfway through. This is the medication working, not something wrong with you.

Week 3-4: By now, most people are settling into a rhythm. Many see their first meaningful weight loss during this window — 3 to 8 pounds is a common range in the first month, though individual results vary widely. You're not at your full therapeutic dose yet, so this is just the beginning. The real results compound over the next several months as your dose is titrated upward.

Important context on stopping: Research from the STEP 1 trial extension found that participants who discontinued semaglutide regained approximately two-thirds of their lost weight within one year. This doesn't mean you'll be on medication forever — some patients successfully transition to maintenance doses or lifestyle-only management — but it's a conversation to have with your provider before making changes.

The critical mindset shift: GLP-1 medications are not a 30-day fix. The clinical trials that showed 15-21% body weight loss ran for 68-72 weeks (roughly 16-18 months). Think of this as a long-term investment in your health, not a quick crash diet. That perspective helps when progress feels slow in the early weeks — it's working, even when the scale doesn't move every day.

MEDVi vs Ro Reviews: What Real Patients Say

Before we share excerpts, a note about online reviews generally: Trustpilot uses automated screening technology to detect fraudulent reviews, but it doesn't independently verify the facts in each review. "Verified" means Trustpilot confirmed a purchase interaction took place — not that every claim is accurate. We looked for patterns across hundreds of reviews, not just cherry-picked highlights.

MEDVi Patient Reviews (4.4 on Trustpilot — 11,498 Reviews)

The pattern across MEDVi's positive reviews is strikingly consistent: affordable pricing, fast approvals, responsive support, and — most importantly — the medication works.

Here are paraphrased highlights from verified patient reviews:

Melany (ConsumerAffairs, November 2025): After being turned down by two other programs, she joined MEDVi and lost 31 pounds — reaching a size 12/14 for the first time in over 15 years. She reported steady progress of 5-6 pounds per month on compounded semaglutide, despite some uncomfortable side effects (constipation being the worst).

James (ConsumerAffairs, November 2025): Tried Hers and Found before switching to MEDVi. Lost 13 pounds in his first 2 months and reports eating about half of what he used to. Called the pricing fair for what's included.

Anonymous patient (ConsumerAffairs, February 2026): Lost 29 pounds, described cravings as manageable, and reported improved energy levels.

What reviewers consistently praise: Fast approvals (24-48 hours), clear all-inclusive pricing, 24/7 support availability, no-hassle process, effective medication

What comes up in negative reviews: Some billing confusion around the intro-to-ongoing price jump ($179 to $299), occasional shipping delays, a few reports of difficulty reaching support during peak times. MEDVi's ConsumerAffairs profile skews more critical than Trustpilot — the complaints cluster around billing disputes and cancellation friction rather than medication quality or safety concerns.

One strong signal: MEDVi responds to 98% of Trustpilot reviews, typically within 24 hours — a response rate that is uncommon in this industry and reflects active issue resolution. Ro responds to 81% of negative Trustpilot reviews.

Sources: Trustpilot.com/review/medvi.org; ConsumerAffairs.com/health/medvi.html

Ro Patient Reviews (3.8 on Trustpilot — 3,153 Reviews)

Ro is a larger, more established telehealth company operating across multiple health verticals (weight loss, hair loss, ED, mental health, and more).

Important note on Ro's Trustpilot score: Ro's 3.7 rating reflects ALL product lines, not just the Body weight loss program specifically. Reviews for hair loss treatments, ED medication, and other services are mixed in with weight loss reviews. A direct comparison of MEDVi's 4.5 (weight-loss-only company) to Ro's 3.7 (multi-vertical company) without this context would be misleading.

Here are paraphrased highlights from verified patient reviews:

Sarah (Trustpilot, January 2026): Praised Ro's insurance concierge team for getting her Wegovy prior authorization approved in under two weeks. She reported losing 18 pounds in her first three months on the program and found the coaching modules helpful for building healthier eating habits.

David (ConsumerAffairs, December 2025): Switched to Ro from another provider specifically for the Wegovy pill option. Appreciated the structured monthly check-ins with his provider and the educational content on nutrition and exercise.

What reviewers consistently praise: Professional, knowledgeable providers. Strong insurance concierge service. The new Wegovy pill option. Useful educational content and coaching.

What comes up in negative reviews: Confusion about the membership fee not including medication (this appears repeatedly). Higher total costs than expected for cash-pay patients. Slower onboarding when using the insurance route.

Disclosure worth noting: Ro's website states that featured patient testimonials on their platform are from members who were compensated for sharing their stories. This doesn't mean those testimonials are fabricated — but it's context you should have when reading them.

Sources: Trustpilot.com/review/ro.co; ConsumerAffairs.com/health/ro.html

Which One Fits Me? The 4-Question Decision Framework

You don't need to overthink this. Answer four questions and you'll know.

Question 1: Does your insurance cover GLP-1 weight loss medication?

  • Yes, confirmed coverage — Lean strongly toward Ro. Their insurance concierge handles the prior authorization paperwork, and your total monthly cost could drop to ~$170-$195 (membership + copay). That's a meaningful savings.
  • No, denied, or unsure — Continue to Question 2.

Question 2: What can you realistically spend per month?

  • Under $350/monthMEDVi is likely your best fit. $179 first month, $299 ongoing, and that's it. No surprises, no stacking costs.
  • $350-$600/month — Both are options. Move to Question 3.
  • Budget is flexible — Move to Question 3 — this becomes about medication preference.

Question 3: How important is the FDA-approved label?

  • I want brand-name medication, no exceptionsRo. They prescribe Wegovy, Zepbound, and Ozempic directly from the manufacturers.
  • I'm comfortable with compounded medication, or I want brand-name through MEDVi's membership routeMEDVi. Their core compounded plans ($179–$299/mo all-inclusive) use an established 39-year-old pharmacy. MEDVi also offers brand-name Wegovy and Zepbound through a $99/month membership + medication cost route for patients who want FDA-approved options but prefer MEDVi's platform. Compounded products are not FDA-approved finished products.

Question 4: How fast do you want to start?

  • As fast as possibleMEDVi. Most patients are approved within 24-48 hours and have medication in hand within days.
  • I can wait for insurance processingRo. The insurance route takes 2-6+ weeks, but the financial payoff is real if coverage comes through.

Your answers should point clearly toward one path. Neither choice is wrong — they serve different situations.

Refunds, Cancellation, and the One Thing to Know Before You Pay

MEDVi's Refund Policy — What It Actually Says

MEDVi's current refund policy is narrower than some earlier marketing language implied. Based on their published cancellation and refund policy, a refund is issued only if you are medically disqualified after payment — for example, if a provider reviews your health intake and determines you are not a candidate for GLP-1 treatment. Ordinary cancellation, dissatisfaction, or deciding the program isn't for you does not trigger a refund.

What this means practically: MEDVi is a subscription — not a trial. If you enroll, receive medication, and then decide to cancel, you will not receive a refund for amounts already charged. This is standard practice across GLP-1 telehealth platforms (Ro included), but it's worth understanding before you enter payment information.

Billing cutoff: To avoid being charged for the next month, you must cancel at least 72 hours before your next scheduled billing date. Cancel via the patient portal chat or by emailing [email protected]. Screenshot your cancellation confirmation and save the email.

Medication already shipped: Compounded medications are prepared specifically for you and cannot be returned. No refund is available on medication that has already been dispensed and shipped — even if you cancel shortly after ordering.

Source: home.medvi.org/cancellation-and-refund-policy; MEDVi Terms and Conditions. Accessed March 30, 2026.

Ro's Cancellation Policy

Cancel anytime from your account settings or by emailing support. Cancel at least 48 hours before your next billing date to avoid another charge. You keep access through the rest of your paid billing cycle. No money-back guarantee on weight loss results.

If your insurance ends up not covering medication, you can switch to Ro's cash-pay medication options or cancel entirely.

Source: Ro.co — How It Works page

How to Avoid Frustration With Either Provider

Regardless of which you choose:

  • Screenshot your enrollment pricing and terms before submitting payment
  • Set a calendar reminder 4 days before each billing date
  • If canceling, get email confirmation and save it
  • Start at the lowest medication dose and titrate up per your provider's instructions (this minimizes side effects)
  • Keep your provider in the loop — message them at the first sign of issues, not after they've snowballed

Are MEDVi and Ro Legit? Provider Verification Checklist

Given the FDA's active scrutiny of the compounded GLP-1 space — including new enforcement actions announced in February 2026 — legitimacy verification should be the first thing you do before paying any online GLP-1 provider. Here's how both stack up.

MEDVi's Credentials (Verified)

Verification PointStatusSource
LegitScript certified Stated on MEDVi website and ConsumerAffairs profileMEDVi.org
Patients treated500,000+ (per MEDVi)MEDVi.org homepage
Pharmacy partnerBelmar Pharma Solutions (est. 1985) — states 503A + FDA-registered 503B facilitiesBelmarPharmaSolutions.com
Licensed prescribersVia OpenLoop Health — licensed in patient's stateMEDVi program description
Cold-chain shippingTemperature-controlled packaging (confirmed in multiple patient reviews)Trustpilot / ConsumerAffairs reviews
Clear refund policy Published on websiteMEDVi.org/refund-policy
Trustpilot rating4.4 (11,498 reviews)Trustpilot.com/review/medvi.org
Available states49 states — all except North Dakota (per MEDVi website)MEDVi.org
FDA warning letter (Feb. 2026)The FDA sent MEDVi a warning letter about marketing language on their website — specifically, product images that showed "MEDVi" on medication labels (the actual compounder is Belmar Pharma Solutions) and "same active ingredient" comparisons to branded drugs. This is a website copywriting issue, not a safety, manufacturing, or medication quality issue. The letter did not cite problems with MEDVi's medication, pharmacy partner, or patient care. Dozens of GLP-1 telehealth companies received similar letters in this enforcement wave.FDA.gov warning letter

Sources: MEDVi.org Safety & Sourcing page; Belmar Pharma Solutions About Us and Quality & Service pages; LegitScript.com

February 2026 FDA Warning Letter — Context

In February 2026, MEDVi received an FDA warning letter — along with dozens of other GLP-1 telehealth companies — as part of a broader enforcement wave. The letter flagged two website marketing issues: product images showing "MEDVi" on medication labels (the actual compounder is Belmar Pharma Solutions), and "same active ingredient" language the FDA considers misleading for compounded products.

The letter did not cite problems with MEDVi's medication quality, safety, pharmacy partner, or patient care. The FDA sent 50+ similar letters to GLP-1 telehealth platforms in 2025-2026. Companies typically respond by updating website copy, and the FDA closes the matter. We'll update this section when a resolution is posted.

Source: FDA Warning Letter — MEDVi, LLC — 721455 — 02/20/2026

Ro's Credentials (Verified)

Verification PointStatusSource
Company establishedFounded 2017 (as Roman Health)Ro.co/about
Manufacturer partnerships Direct integration with Eli Lilly (LillyDirect) and Novo Nordisk (NovoCare)Ro.co program details
Licensed prescribers In-house and partner providers, licensed in patient's stateRo.co
FDA-approved medications Wegovy, Zepbound, Ozempic — brand-name from manufacturersFDA prescribing information
Insurance support In-house insurance concierge handles prior authorizationsRo.co/weight-loss
Trustpilot rating3.8 (3,153 reviews — across ALL product lines, not weight loss only)Trustpilot.com/review/ro.co
Venture funding / scaleOver $1B raised; one of the largest telehealth companies in the U.S.Public reporting

Sources: Ro.co About page; Trustpilot.com/review/ro.co; public reporting on Ro funding rounds

How to Verify ANY GLP-1 Provider (Use This Checklist)

Whether you're considering MEDVi, Ro, or anyone else — run through these before you pay:

  • Licensed prescriber? Verify your provider's medical license through your state's medical board website. Takes 2 minutes.
  • State-licensed pharmacy? Check the pharmacy name against your state's board of pharmacy records. Legitimate pharmacies will be listed.
  • Cold-chain shipping for injectables? The medication should arrive cold with visible ice packs. If it arrives warm, contact your provider before using it.
  • Clear refund and cancellation policy? If you can't find it on the website, that's a red flag.
  • Real contact information? Physical address, phone number, email — not just a web form.
  • LegitScript or NABP certification? Either adds a layer of independent verification.

Red Flags That Should Stop You Immediately

  • No prescription required (illegal for GLP-1s)
  • Product labeled "for research purposes only" or "not for human consumption"
  • No identifiable pharmacy on the label or packaging
  • Prices under $100/month for injectable GLP-1s (unrealistically low)
  • No medical intake process or provider consultation
  • Claims that their product is "the same as" or a "generic version of" Wegovy/Zepbound/Ozempic (the FDA has explicitly warned against these claims)

Source: FDA — "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss," updated February 2026

Can You Use Insurance With MEDVi or Ro?

MEDVi: No. MEDVi operates entirely on a cash-pay basis. They don't bill insurance, submit claims, or handle prior authorizations. The upside: zero insurance delays, zero denials, zero paperwork, and your price is your price from day one. You can pay with HSA/FSA cards and submit receipts for potential reimbursement on your own.

Ro: The membership ($149/month) is cash-pay only — insurance won't cover it. But Ro does accept insurance for the medication portion. Their insurance concierge team handles paperwork, pursues prior authorization, and tracks the process through their app. If your plan covers Wegovy or Zepbound, your medication cost could drop to just a copay ($25-$50/month for some plans).

The catch: Medicaid, TRICARE, and many commercial plans still exclude GLP-1 medications for weight loss. Medicare Part D historically excluded them too — but the Medicare GLP-1 Bridge (launched July 1, 2026) now covers Wegovy and Zepbound for eligible beneficiaries at $50/month through December 31, 2027. Even with covered plans, prior authorization approval isn't guaranteed — insurers can deny coverage and often do.

If Ro's insurance route gets denied, you're left with their cash-pay medication prices plus the $149 monthly membership. That's when the math shifts dramatically toward MEDVi.

Alternatives Worth Knowing About

If neither MEDVi nor Ro feels right, here's the competitive landscape. We want you making the best decision for you — even if that means choosing a different provider entirely. See also our MEDVi vs Yucca Health comparison and full MEDVi review for deeper analysis.

ProviderModelApprox. Monthly CostMeds Included?Insurance?Best For
MEDViAll-inclusive cash-pay$299/mo (semaglutide, verified)Cash-pay patients wanting simplicity + value
RoMembership + separate meds$294-$494+/mo (verified)Patients with insurance coverage
HersAll-inclusive (bulk discount)~$199/mo (with prepaid commitment — verify current terms)Budget-conscious if willing to commit upfront
Remedy MedsAll-inclusive cash-pay~$299/mo (verify current pricing)Similar model to MEDVi
LifeMDAll-inclusive with insurance optionVaries (verify current pricing)PartialPatients wanting combination therapy approach
Your PCP + local pharmacyTraditional healthcareVaries widelyVia prescriptionPeople with great insurance and established doctor relationships

A Closer Look at Key Alternatives

Hers has gained traction with aggressive pricing — $199/month is genuinely competitive. The catch: that rate typically requires committing to 6 or 12 months upfront, meaning you're paying $1,200-$2,400 before you inject a single dose. If you experience intolerable side effects in month 2 or hit your goal weight earlier than expected, getting unused months refunded can be a challenge. MEDVi's month-to-month model avoids this entirely — you pay as you go and stop when you want. See our full MEDVi vs Hers comparison for a detailed side-by-side breakdown.

Remedy Meds is structurally similar to MEDVi — all-inclusive cash-pay model, compounded GLP-1s, competitive monthly pricing. Their differentiator is a guarantee tied to losing at least 10% of your body weight. If you're comparing the two, look closely at pharmacy partnerships, support availability, and reviews.

Your primary care doctor remains an excellent option if you have a strong relationship with your PCP and your insurance covers brand-name GLP-1 medications. The tradeoff is typically less specialized weight loss support, fewer touch points between visits, and the possibility that your PCP may not be as experienced in GLP-1 dose titration as providers who specialize in it.

The telehealth landscape is changing fast. New providers launch regularly, pricing shifts, and the regulatory environment (especially around compounded medications) continues to evolve. Whatever you choose today, review your options again in 6 months. The best provider a year from now might not be the same as the best provider today.

Frequently Asked Questions

Is MEDVi cheaper than Ro?

For cash-pay patients without insurance, yes — by approximately $1,800-$2,300 per year for semaglutide treatment. MEDVi's all-inclusive pricing eliminates the membership-plus-medication double billing that makes Ro more expensive out-of-pocket. If your insurance covers the medication cost, Ro can be cheaper overall.

Does MEDVi prescribe the same medication as Ro?

Not exactly. MEDVi is a hybrid platform. Their core all-inclusive plans ($179–$299/mo) use compounded semaglutide and tirzepatide — not FDA-approved finished products. MEDVi also offers a $99/month membership route that provides access to brand-name Wegovy and Zepbound, similar to how Ro operates. Ro's primary offering is FDA-approved brand-name medication from Novo Nordisk and Eli Lilly. Compounded medications have not undergone FDA review as finished products and are not interchangeable with or equivalent to the branded versions.

Can I switch from Ro to MEDVi (or vice versa)?

Yes. Both are month-to-month with no long-term contracts. To avoid being charged for another cycle, cancel at least 72 hours before your next billing date (MEDVi) or 48 hours before (Ro). Sign up for the other provider after cancellation. Your new provider will conduct their own medical evaluation — they will not carry over your existing prescription.

Are GLP-1 medications safe?

GLP-1 receptor agonists are among the most extensively studied weight loss medications ever developed. The FDA approved semaglutide (Wegovy) and tirzepatide (Zepbound) based on large-scale clinical trials involving thousands of participants. Common side effects (nausea, constipation) typically improve over time. Serious risks exist — the boxed warning about thyroid tumors is the most important one.

Does MEDVi have a money-back guarantee?

MEDVi's current refund policy offers a refund only if you are medically disqualified after payment — meaning a provider reviews your case and determines you are not eligible for GLP-1 treatment. Ordinary cancellation, dissatisfaction, or stopping the program voluntarily does not qualify for a refund. Always review MEDVi's current cancellation and refund policy at home.medvi.org/cancellation-and-refund-policy before enrolling. Ro does not offer a money-back guarantee.

What if I'm afraid of needles?

Both providers offer needle-free options. MEDVi offers sublingual tablets you dissolve under your tongue daily. Ro offers the Wegovy pill, an FDA-approved daily oral semaglutide tablet. Either eliminates the need for self-injection.

How fast can I start?

MEDVi: Most patients approved within 24-48 hours, medication delivered within days. Ro cash-pay: medication can ship within about a week. Ro insurance route: 2-6+ weeks due to prior authorization processing.

Can I use my HSA or FSA?

MEDVi accepts HSA/FSA payments. Ro does not currently list HSA/FSA acceptance for their Body Program membership — confirm directly with Ro support before assuming coverage. Eligibility also depends on your specific plan administrator's rules.

What if my insurance denies coverage through Ro?

Ro gives you two options: switch to their cash-pay medication pricing (separate from the $149 membership) or cancel. If denied, compare MEDVi's all-inclusive pricing against Ro's combined costs before deciding.

Is the Wegovy pill available through MEDVi?

Yes — through MEDVi's $99/month membership route. MEDVi's hybrid platform now includes access to brand-name Wegovy (including the oral pill) and Zepbound via a $99/month membership with medication billed separately. Their core all-inclusive compounded plans ($179–$299/mo) still use compounded sublingual tablets as the needle-free option — a different product from the brand-name Wegovy pill. Confirm current availability and pricing directly with MEDVi during enrollment.

How long will I need to stay on GLP-1 medication?

This varies by individual. Research from the STEP 1 trial extension showed that participants who stopped semaglutide regained approximately two-thirds of their lost weight within a year. Many patients and providers view GLP-1 therapy as a long-term or ongoing treatment. Work with your provider to determine the right timeline for your situation.

What's the difference between semaglutide and tirzepatide?

Semaglutide works on one hormone pathway (GLP-1). Tirzepatide works on two (GLP-1 and GIP). Clinical trials show tirzepatide produces slightly greater average weight loss (~21% vs ~15% of body weight). Both are effective. Tirzepatide is generally more expensive through either platform.

What if my MEDVi medication arrives warm?

Don't assume it's safe to use. Follow the storage instructions included with your medication and contact MEDVi support immediately. Document the packaging condition with photos and request guidance on whether a replacement is needed. Reputable providers will replace compromised shipments at no additional charge.

Is Ro available in my state?

Ro is available in all 50 states plus Washington, DC. Some states have telehealth-specific requirements that may affect how quickly you can be seen or what type of initial appointment is needed.

Does Ro include medication in the membership fee?

No. This is the most common source of confusion in Ro reviews. The $149/month membership covers provider access, coaching, the app platform, and labs. Your GLP-1 medication is an additional, separate charge based on what you're prescribed and whether insurance covers it.

Will I gain the weight back if I stop taking GLP-1 medication?

Research suggests most people do regain a significant portion of lost weight after discontinuing GLP-1 therapy. The STEP 1 trial extension found that participants regained roughly two-thirds of their weight loss within one year of stopping semaglutide. Some patients taper off gradually, some stay on a maintenance dose indefinitely, and some transition to lifestyle-only maintenance.

Can I take GLP-1 medications if I have diabetes?

Yes — semaglutide (Ozempic) and tirzepatide (Mounjaro) were originally developed and FDA-approved specifically for type 2 diabetes management. However, dosing and monitoring may differ if you have diabetes, and your provider needs to know about all medications you're currently taking to avoid interactions.

Are there any foods I should avoid while on GLP-1 medication?

There are no strict dietary prohibitions with GLP-1 medications, but most patients find that high-fat, greasy, or very large meals make nausea worse — especially in the early weeks. Many patients naturally shift toward smaller portions and lighter foods because their appetite is reduced.

Does MEDVi or Ro offer tirzepatide (the Zepbound/Mounjaro ingredient)?

Yes, both do. MEDVi offers compounded tirzepatide injections (starting at $349 first month) and compounded tirzepatide sublingual tablets (starting at $279). Ro offers Zepbound (FDA-approved tirzepatide) starting at $299/month for the lowest dose (cash-pay), with higher doses costing up to $449/month plus the $149 membership.

Final Verdict: MEDVi vs Ro in 2026

After pulling apart every pricing page, reading FDA labels, analyzing thousands of reviews, and running the real cost math — here's where we land.

Choose MEDVi if:

  • You want a single monthly price that covers everything — medication, provider, shipping (compounded core plans from $179 first month, $299 ongoing)
  • You're paying cash and want all-inclusive pricing that stays flat regardless of dose
  • You want fast approval and medication delivery — most patients have medication in hand within days
  • You're comfortable with compounded medication from Belmar Pharma Solutions, an established pharmacy operating since 1985
  • You want brand-name Wegovy or Zepbound but prefer MEDVi's platform — available through their $99/month membership + medication cost route
  • You value a provider with 4.4★ / 11,498 Trustpilot reviews and a 98% review response rate

Choose Ro if:

  • You have insurance that covers GLP-1 medication — Ro's concierge handles prior auth paperwork and can reduce your medication cost to just a copay
  • Having an FDA-approved, brand-name drug (Wegovy, Zepbound) directly from the manufacturer is your priority — Ro sources these through Novo Nordisk's NovoCare and Eli Lilly's LillyDirect
  • You want the Wegovy pill (FDA-approved daily oral semaglutide) through Ro's established program at the lowest available starting price ($149/mo starting dose)
  • Structured health coaching with a formalized curriculum (Body Program) appeals to you — includes 1-on-1 coaching sessions and app-based tracking
  • You want full nationwide availability (all 50 states + DC) and a large, established telehealth brand

The honest bottom line: MEDVi has evolved into a hybrid platform — not strictly compounded-only. For cash-pay patients, their all-inclusive compounded plans at $179–$299/month remain the clearest value in this comparison. For patients who want brand-name medication, both providers now offer it; the difference is that Ro's insurance concierge can make brand-name medication dramatically cheaper if your plan covers it.

If you're paying cash: MEDVi's all-inclusive $299/month compounded plan is simpler and more predictable than Ro's membership-plus-medication structure. MEDVi's price stays flat regardless of dose; Ro's medication costs increase as your dose goes up. For most cash-pay patients, the annual savings with MEDVi are significant.

If you have insurance that covers GLP-1s: Ro's insurance concierge is a genuine competitive advantage — their team handles prior authorization paperwork to get brand-name Wegovy or Zepbound covered, potentially reducing your total cost to just a copay plus the $149 membership. That math can easily beat MEDVi's cash-pay pricing.

Before you enroll in either program: Read the refund and cancellation policy carefully. Neither provider offers an easy money-back option for ordinary cancellations. MEDVi refunds only if you are medically disqualified. Ro has no weight-loss guarantee at all. Screenshot your terms at enrollment.

The science behind these medications is well-established. Whichever direction fits your situation, the most important step is confirming your eligibility and understanding the full cost before you commit.

Sources

  1. MEDVi.org — Official pricing, program details, Safety & Sourcing page, Terms & Conditions. Accessed March 30, 2026.
  2. MEDVi — Cancellation and Refund Policy. home.medvi.org/cancellation-and-refund-policy Accessed March 30, 2026.
  3. MEDVi GLP-1 Program — Program details, brand-name membership route. glp.medvi.org Accessed March 30, 2026.
  4. Ro.co/weight-loss — Official Body Program pricing, How It Works page. Accessed March 30, 2026.
  5. Ro — Terms of Use. ro.co/terms-of-use Accessed March 30, 2026.
  6. U.S. Food and Drug Administration — "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss." Updated February 4, 2026. FDA.gov
  7. U.S. Food and Drug Administration — "FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs." February 6, 2026. FDA.gov
  8. U.S. Food and Drug Administration — FDA announcement on compounded GLP-1 drug status. March 3, 2026. FDA.gov
  9. U.S. Food and Drug Administration — "Compounding and the FDA: Questions and Answers." Updated September 2025.
  10. Wilding, J. P. H., et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 384(11), 989-1002. DOI: 10.1056/NEJMoa2032183
  11. Jastreboff, A. M., et al. (2022). "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 387(4), 327-340. DOI: 10.1056/NEJMoa2206038
  12. Wilding, J. P. H., et al. (2022). "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension." Diabetes, Obesity & Metabolism, 24(8), 1553-1564. DOI: 10.1111/dom.14725
  13. FDA Prescribing Information — Wegovy (semaglutide injection and oral tablet). FDA.gov
  14. FDA Prescribing Information — Zepbound (tirzepatide injection). FDA.gov
  15. Trustpilot.com/review/medvi.org — 4.4 stars, 11,498 reviews. Accessed March 30, 2026.
  16. Trustpilot.com/review/ro.co — 3.8 stars, 3,153 reviews. Accessed March 30, 2026.
  17. ConsumerAffairs.com/health/medvi.html — Verified customer reviews. Accessed March 30, 2026.
  18. ConsumerAffairs.com/health/ro.html — Verified customer reviews. Accessed March 30, 2026.
  19. Belmar Pharma Solutions — About Us, Quality and Service, 503B Compounding Facility pages. belmarpharmasolutions.com
  20. MEDVi — Safety & Sourcing / 503B Pharmacy Standards page. medviglp1.com
  21. Wilson Sonsini — "FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers." September 2025.
  22. U.S. Food and Drug Administration — Warning Letter: MEDVi, LLC dba MEDVi — 721455 — 02/20/2026. FDA.gov

About This Guide

Author: WPG Research Team

Published: February 14, 2026

Last editorial update: March 30, 2026

Pricing last verified: March 30, 2026

Regulatory review last checked: March 30, 2026

Next full review: May 2026

Our update commitment: We verify all pricing and program details monthly by checking official provider websites. FDA safety information is reviewed quarterly. If you notice anything outdated or inaccurate, contact us and we'll investigate and update within 48 hours.